D.E. Shaw & Co’s NantHealth, Inc NH Stock Holding History

D.E. Shaw & Co’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,557	Closed	-$307K	–	3662
2016 Q3	$307K	Buy	+1,557	New	+$286K	﹤0.01%	3039

Other funds holding NH

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's NH Position: Q4 2016 in Review

D.E. Shaw & Co sold out of NantHealth, Inc (NH) in Q4 2016, closing a stake of 1,557 shares — an estimated $307K sold.

D.E. Shaw & Co first reported a position in NH in Q3 2016 and held it in 1 quarter. The position peaked at $307K in Q3 2016. 44 funds tracked by Wall St. Rank hold NH as of Q4 2016.

D.E. Shaw & Co reported no remaining NantHealth, Inc position as of Q4 2016 after selling out during the quarter.
D.E. Shaw & Co sold 1,557 NantHealth, Inc shares in Q4 2016, an estimated $307K.
D.E. Shaw & Co first reported a position in NantHealth, Inc in Q3 2016 and held it in 1 quarter.
D.E. Shaw & Co's NantHealth, Inc position peaked at $307K in Q3 2016.
44 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2016.

Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.